An IL-2 paradox: blocking CD25 on T cells induces IL-2-driven activation of CD56(bright) NK cells

Daclizumab (Dac), an Ab against the IL-2R alpha-chain, inhibits brain inflammation in patients with multiple sclerosis, while expanding CD56(bright) immunoregulatory NK cells in vivo. We hypothesized that this unexpected expansion is paradoxically IL-2 driven; caused by the increased availability of...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 185; no. 2; p. 1311
Main Authors Martin, Jayne F, Perry, Justin S A, Jakhete, Neha R, Wang, Xiang, Bielekova, Bibiana
Format Journal Article
LanguageEnglish
Published United States 15.07.2010
Subjects
Online AccessGet full text

Cover

Loading…